Clicky

Sunday, November 8, 2026

Breaking News

Latest SEC filings as they come in

Takeda's Teresa Bitetti to Sell 46,609 Shares Amid Tax Obligations

Teresa Bitetti, Takeda's president of Global Oncology, files to sell 46,609 shares to meet tax obligations, reflecting ongoing trends in executive stock management.

ACPS P.G. Trust Disposes of Hyatt Shares in Recent Filing

ACPS P.G. Trust reports significant share disposals of Hyatt Hotels Corp, signaling a strategic investment shift.

Settlement T-551-7 Reports Class B Stock Transaction for Hyatt

Settlement T-551-7 has reported a significant transaction involving Hyatt Hotels Corp's Class B Common Stock, indicating changes in ownership dynamics.

Keller Frank Disposes of 732 Shares of PayPal Stock

Keller Frank, PayPal officer, sold 732 shares of stock under a Rule 10b5-1 plan, reflecting ongoing adjustments in the tech sector.

Rodriguez acquires 550,000 shares in New ERA Energy

Jose Reynaldo Rodriguez, COO of New ERA Energy & Digital, acquires 550,000 shares, indicating confidence in the company's future.

Rodriguez Files Form 3, Reports No Securities Ownership

Jose Reynaldo Rodriguez files Form 3 with SEC, indicating no securities ownership in New Era Energy & Digital, Inc., emphasizing compliance and transparency.

Cheng Jordan Sells 2,800 Shares of Happen, Inc.

Cheng Jordan, General Counsel at Happen, Inc., sold 2,800 shares of common stock, leaving him with 103,613 shares. The transaction was part of a trading plan.

CEO Nelson Charles Lawrence Reports Stock Transactions

Nelson Charles Lawrence, CEO of New Era Energy & Digital, reports significant stock transactions, emphasizing transparency and accountability in executive compensation.

MACOM CFO John Kober Reports Stock Transaction

Senior VP and CFO John Kober of MACOM Technology Solutions reports stock transaction, reflecting ongoing management activities and transparency.

TSPV P.G. Trust Reports Stock Transactions for Hyatt Hotels

TSPV P.G. Trust has disclosed transactions involving Hyatt Hotels' Class B Common Stock, highlighting active investment management in the hospitality sector.

Immunovant CEO Eric Venker Sells 200,000 Roivant Shares

Eric Venker, CEO of Immunovant, sold 200,000 shares of Roivant Sciences, reflecting strategic shifts within the pharmaceutical industry.

Director John Mutch Sells 750 Shares of Agilysys Stock

John Mutch, director at Agilysys Inc, sells 750 shares in recent SEC filing, reflecting ownership changes and industry trends in tech.

JSPV P.G. Trust Reports Transactions in Hyatt Hotels Stock

JSPV P.G. Trust disclosed transactions involving Hyatt Hotels' Class B Common Stock, highlighting ongoing investment activity in the hospitality sector.

Kiniksa Pharmaceuticals reports significant stock sale by officer

Kiniksa Pharmaceuticals International, plc reports a major stock sale by Sanj K. Patel, raising over $51 million in the pharmaceutical sector.

Sestak Ondrej Increases Stake in New ERA Energy & Digital

Sestak Ondrej reports increased ownership in New ERA Energy & Digital, impacting the crude petroleum and natural gas sector.

DJPS P.G. Trust Disposes of Hyatt Hotels Shares

DJPS P.G. Trust reported significant transactions involving Hyatt Hotels Corp's Class B Common Stock, reflecting strategic movements in the hospitality sector.

Southern Copper director acquires 400 shares of stock

Luis Miguel Palomino Bonilla, a director at Southern Copper Corp, acquired 400 shares of stock, reflecting confidence in the company's future.

New ERA Energy's President Reports Major Stock Transaction

New ERA Energy & Digital, Inc. reports a significant stock transaction by President Gray Everett Willard II, reflecting industry trends in crude petroleum.

MACOM CEO Stephen G. Daly Sells Shares to Cover Taxes

MACOM's CEO Stephen G. Daly sold shares to cover tax obligations, impacting the company's stock ownership landscape amid semiconductor industry scrutiny.

Moat Ross to Sell Over 103,000 Shares of Kiniksa Pharmaceuticals

Moat Ross files to sell over 103,000 shares of Kiniksa Pharmaceuticals, valued at approximately $9.75 million, highlighting trends in stock compensation.

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →